Corebridge Financial’s Enliven Therapeutics ELVN Stock Holding History

Corebridge Financial’s Portfolio ELVN Stock Details ELVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$353K	Buy
2024 Q4	$394K	Sell
2024 Q3	$481K	Sell
2024 Q2	$443K	Buy